Does CANAKINUMAB Cause Platelet count decreased? 43 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 43 reports of Platelet count decreased have been filed in association with CANAKINUMAB (Ilaris). This represents 0.4% of all adverse event reports for CANAKINUMAB.
43
Reports of Platelet count decreased with CANAKINUMAB
0.4%
of all CANAKINUMAB reports
4
Deaths
28
Hospitalizations
How Dangerous Is Platelet count decreased From CANAKINUMAB?
Of the 43 reports, 4 (9.3%) resulted in death, 28 (65.1%) required hospitalization, and 6 (14.0%) were considered life-threatening.
Is Platelet count decreased Listed in the Official Label?
Yes, Platelet count decreased is listed as a known adverse reaction in the official FDA drug label for CANAKINUMAB.
What Other Side Effects Does CANAKINUMAB Cause?
Pyrexia (1,327)
Inappropriate schedule of drug administration (1,238)
Drug ineffective (1,078)
Inappropriate schedule of product administration (944)
Pain (858)
Condition aggravated (771)
Malaise (684)
Off label use (557)
Arthralgia (555)
Rash (505)
What Other Drugs Cause Platelet count decreased?
LENALIDOMIDE (7,491)
NIRAPARIB (4,102)
ELTROMBOPAG OLAMINE (3,419)
RUXOLITINIB (3,028)
RITUXIMAB (2,404)
VENETOCLAX (2,367)
DEXAMETHASONE (2,321)
PALBOCICLIB (2,277)
CYCLOPHOSPHAMIDE (1,894)
RIBAVIRIN (1,701)
Which CANAKINUMAB Alternatives Have Lower Platelet count decreased Risk?
CANAKINUMAB vs CANDESARTAN
CANAKINUMAB vs CANDESARTAN CILEXETIL
CANAKINUMAB vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE
CANAKINUMAB vs CANGRELOR
CANAKINUMAB vs CANIS LUPUS FAMILIARIS SKIN